July 2022 - Page 3 of 9 - NetworkNewsWire

TuesdayJul 26, 2022 9:00 am

Quantum Computing Has Arrived

NetworkNewsWire Editorial Coverage: The world may be on the cusp of a new generation of computing. Its name? Quantum computing. Much like its precursors, quantum computing doesn’t have a sole inventor or a single brand; it is the collective product of decades of work by many of the brightest minds in science and technology. The nascent industry is highly complex employing varied approaches to harness the power of quantum mechanics to solve challenges that classic computers simply cannot handle. A paradigm shift of computing may be coming, and it would have a far-reaching impact. Currently real, practical quantum computing applications…

TuesdayJul 26, 2022 9:00 am

Odyssey Health, Inc. (ODYY), Determined to Introduce the Market’s First FDA Approved Concussion Treatment Drug

PBS News Hour estimates that, for college students, concussions cost between $446 million and $1.5 billion annually, while for high school students the cost ranges from $5.4 billion to $19.2 billion Odyssey, through its flagship product, PRV-002, hopes to offer the first FDA-approved drug treatment for concussions Once approved, Odyssey is confident that PRV-002 will bring relief to thousands of victims, reduce the cost of concussion treatment and allow victims to lead normal, healthy, and productive lives The company is currently scheduling a meeting with the FDA to present findings from the phase I trial, as it identifies phase II…

MondayJul 25, 2022 12:45 pm

Cub Crafters Inc. Is ‘One to Watch’

CubCrafters owns 15 undeveloped acres at McAllister Field for potential expansion of operations The company recently opened a new 11,000-square-foot Customer Completion Center Cost and timeline of FAA Certification represents a significant barrier to entry The company introduced its CC19-180 XCub aircraft in June 2016, completing the six-year project without using any outside investment The company recently released new variants of the XCub offering floats and more engine horsepower New nosewheel configurations open up the company’s product line to 85% of all pilots Only 10-12% of CubCrafter’s sales are international, though it represents 50% of the market demand – an…

MondayJul 25, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patents Recently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in Japan The patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent family Lexaria also submitted a briefing book to the FDA to facilitate its upcoming pre-Investigational New Drug (“IND”) meeting with the agency “We are extremely pleased to have received our first patent protecting our…

MondayJul 25, 2022 11:15 am

Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study

Silo Pharma produced initial batch of SPU-21 liposomes for rheumatoid arthritis study conducted by CRO Frontage Laboratories Recent company research revealed SPU-21 liposomes can target inflamed epithelium, suggesting use for targeted drug delivery SPU-21 can be used for development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis Company recently announced positive results in subcutaneous delivery of novel liposomes vs. intravenous injection Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company that focuses on fusing traditional therapeutics with psychedelic research, recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage…

MondayJul 25, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Realize ESG Strategies Through Comprehensive Energy Analysis and Environmentally Friendly Upgrades to Facilities

Nearly a decade has passed since approximately 200 government entities met in Paris, ratifying a binding agreement to work toward reducing pollution and its negative impacts on global climate Louisiana-based Correlate Infrastructure Partners is helping to educate corporate clients on both the affordability and potential profit offered by ESG solutions that reduce their greenhouse gas impact CIPI’s Correlate, Inc. and Loyal Enterprises LLC (dba Solar Site Design) subsidiaries provide related help on acquisitions and project development, as well as resource financing A recent report by consulting firm McKinsey & Company forecasts growing adoption of renewable energy solutions by the public,…

MondayJul 25, 2022 9:45 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Charges Ahead as Clean Tech Company on the Right Track to Providing Optimal Inverter Technology

Hillcrest announces AGM results; all seven members of Board of Directors are re-elected while new board chair David Farrell is appointed Company exits fossil-fuel business and completes transition to clean tech market where it continues to develop inverter technology empowering next generation of more efficient and powerful electric vehicles Hillcrest reaches key milestone as it completes proof of concept testing of its inverter technology, with the commercial prototype soon to be available in Q4 2022 Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA), a Canadian cleantech company developing technologies for innovative electrical solutions such as powertrains and grid-connected renewable…

MondayJul 25, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study

Data from newly acquired study could accelerate clinical development of CYBN’s CYB004 by nine months The pivotal study was designed with four primary objectives Cybin’s proprietary substance has potential to effectively treat anxiety disorders, including GAD and SAD Cybin (NEO: CYBN) (NYSE American: CYBN) has completed the acquisition of the largest dimethyltryptamine (“DMT”) study to date, a Phase 1 N,N-DMT study that provides key data relating to the company’s proprietary CYB004 substance (https://nnw.fm/xsuq7). Information from the study is expected to help the company accelerate by up to nine months its clinical development pathway of CYB004. “With the closing of this transaction…

FridayJul 22, 2022 10:00 am

Looking for an Edge? Golden Matrix Group Inc. (NASDAQ: GMGI) to Release Peer-to-Peer Esports Betting Product

GMGI CEO says new P2P Esports offering coming “quite soon” Gaming operators have need for new products to grow market share New product overcomes challenges related to compliance in Esports gambling If you’re paying attention to the sports betting market, you’re seeing companies big and small looking for edges to capture market share from competition in a fierce, albeit huge, marketplace. It’s tough to carve out profits when, in the words of Brian Goodman, CEO of Golden Matrix Group (NASDAQ: GMGI), “everyone [is] fishing in the same pond.” Companies must be differentiated, as is Golden Matrix, a provider of turnkey…

FridayJul 22, 2022 9:45 am

Industry Experts to Share Invaluable Insights at the Premier EV Charging Conference in August 2022

The EV Charging Conference 2022 is a 2-day virtual event designed to optimize education, learning, and networking among industry professionals in the electric vehicle market and other participants. The highly specialized event focuses on addressing fundamentals at residential and commercial levels to drive ROI across the EV landscape and clean energy. Key Details The push for NetZero is creating a massive, untapped opportunity for EV Charging Reinvent your electric strategy for residential or commercial properties Thought leaders will share their knowledge, skills, and expertise to enable the successful integration of profitable EV charging into your organization The forthcoming EV Charging…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: July 2022